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alters cerebral neurotransmitters level 
and impairs brain tissue of swiss mice
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Abstract 
Background: Potassium bromate (KBrO3) is widely used as a food additive and is a major water disinfection by‑prod‑
uct. The present study reports the side effects of KBrO3 administration on the brain functions and behaviour of albino 
mice.
Methods: Animals were divided into three groups: control, low dose KBrO3 (100 mg/kg/day) and high dose KBrO3 
(200 mg/kg/day) groups.
Results: Administration of KBrO3 led to a significant change in the body weight in the animals of the high dose 
group in the first, second and the last weeks while water consumption was not significantly changed. Neurobehavio‑
ral changes and a reduced Neurotransmitters levels were observed in both KBrO3 groups of mice. Also, the brain level 
of reduced glutathione (GSH) in KBrO3 receiving animals was decreased. Histological studies favoured these biochem‑
ical results showing extensive damage in the histological sections of brain of KBrO3‑treated animals.
Conclusions: These results show that KBrO3 has serious damaging effects on the central nervous system and there‑
fore, its use should be avoided.
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Background
Potassium bromate (KBrO3) is widely used as a flour 
improver that acts as a maturing agent [1]. During the 
last 90  years, it has been used as a food additive [2]. It 
acts principally in the late dough stage giving strength 
and elasticity to the dough during the baking process in 
addition to promoting the rise of bread. KBrO3 is also 
used in cheese production, beer making and is commonly 
added to fish paste products [3]. Also, it is used in phar-
maceutical and cosmetic industries and is a constituent 
of cold wave hair solutions [2]. Moreover, KBrO3 can 
appear as a byproduct in an ozonization of water contain-
ing bromide. As a result of KBrO3 biotransformation, free 
radicals’ generation can cause oxidative damage to essen-
tial cellular macro molecules, leading to marked nephro-
toxicity and cancer in experimental animals [4]. Indeed, 
many previous reports have documented that KBrO3 can 
induce multiple organ toxicity in humans and experi-
mental animals [5–7]. KBrO3 is highly irritating and inju-
rious to tissues especially those of the central nervous 
system (CNS) and kidneys [8]. Many cases of accidental 
poisoning in children resulting from ingestion of bromate 
solution and sugar contaminated with bromate were 
reported as the source of mild poisoning in New Zealand 
[9]. Consequently, KBrO3 has been prohibited in sev-
eral countries like United Kingdom, Nigeria and Canada 
[2]. Toxicological studies have convincingly shown that 
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KBrO3 affects the neurobehavioral (motor equilibrium 
performance and spontaneous locomotor activity) status 
of guinea pigs [10]. KBrO3 induced detrimental effects 
on auditory brainstem response of guinea pigs whereas 
it caused Otto-neurotoxicity mainly through the periph-
eral auditory nerve [11]. Behavioral changes are usually 
associated with a disturbance in neurotransmitters [12]. 
Acetylcholine, dopamine and serotonin are common 
neurotransmitters that can directly or indirectly influ-
ence neurons, thereby affecting behavior [13]. Behavio-
ral changes are also associated with oxidative stress [14]. 
It is known that KBrO3 induces oxidative stress in tis-
sues [15–18] that could be the basis of bromate-induced 
behavioral changes. Moreover, KBrO3 induces hemor-
rhage, neuronal degeneration and vacuolation of the 
brain tissue sections [19]. The present study attempts to 
assess the effect of oral administration of KBrO3 on the 
behavioral changes, neurotransmitters, antioxidant status 
and brain histomorphology of white albino mice using 
two different doses of KBrO3 to compare their effects.
Methods
Animals
Thirty (30) adult male albino mice (Mice musculus) with 
an average weight of 30.2 ±  4.24  g were obtained from 
animal house- College of pharmacy- King Saud Univer-
sity and maintained and monitored in a specific path-
ogen-free environment. All animal procedures were 
performed in accordance with the standards set out in 
the Guidelines for the Care and Use of Experimental Ani-
mals issued by the Committee for the Purpose of Control 
and Supervision of Experiments on Animals (CPCSEA). 
The study protocol was approved by the Animal Ethics 
Committee at King Saud University. All animals were 
allowed to acclimatize in plastic cages inside a well-
ventilated room for one week prior to the experiment. 
The animals were maintained under standard labora-
tory conditions (temperature of 23  °C, relative humidity 
of 60–70 % and a 12-hour light/dark cycle), fed a diet of 
standard commercial pellets and given water ad libitum.
Potassium bromate preparation and dosing schedule
Potassium bromate salt, a product of British drug home 
limited, Poole England was supplied in its white crys-
talline form by ASILA chemicals (Saudi Arabia). It was 
then dissolved in water to prepare the 100  mg/kg dose 
and the 200  mg/kg dose. Animals were divided into 3 
groups as follows: Group (I) control group (was given 
distilled water); Group (II) Low dose KBrO3 group (was 
given 100  mg/kg); Group (III) High dose KBrO3 group 
(was given 200  mg/kg). KBro3 was orally administered 
daily through oral intubation at the two doses of 100 and 
200 mg/kg/day for 42 days. The doses used in the current 
study were adjusted according to the LD50 calculations 
carried out by Kurokawa et al. [24].
Monitoring of water consumption and body weight 
changes
Daily water consumption was monitored for all animals 
in the three groups. The animals were weighed prior to 
the commencement of administration and in subse-
quent weeks during the experiment period. At the end 
of administration, the mice were sacrificed by cervical 
dislocation.
Behavioral studies
Ten animals from each group were used in the current 
study. For testing, the animals were brought in a room 
(25  °C) of dim red light reserved for that purpose. All 
tests were conducted blindly by the same experimenter 
[20]. Except for Morris maze experiment, all experiments 
were carried out during the 3rd and the 6th weeks.
T‑maze conducting assay
All animal’s groups were deprived from food all night 
before this examination. The elevated T-maze con-
sists of three closed arms to be T like structure. The 
main arm (100 × 10 × 20 cm) and the two lateral arms 
(40  ×  10  ×  20  cm) at an elevation of 20  cm above the 
floor. At the end of the right lateral arm, the rodent food 
was placed. Hungry animals were placed in the termi-
nal end of the main arm of the elevated T-maze facing 
the passage to the two lateral arms, and left to explore 
the maze for one min then the animal removed from the 
maze and kept in its cage for 2  hrs and replaced in the 
same position in the main arm and the behavior analyzed 
for 5  min. Both of the time spent exploring the arms to 
reach food, and the time spent in the food arm in seconds, 
were determined. The frequency and time of entering the 
food lateral arm was considered to be memory reflector.
Grip‑strength meter assay
The Ugo Basile 47,200-Grip-Strength Meter (COMERIO-
Varese, Italy) is suitable for mice and can automatically 
measures grip-strength (i.e. peak force and time resist-
ance) of forelimbs in mice. The aim was to assess fore-
limbs muscle strength. Each animal was tested three 
times and the peak force of each mouse was recorded. 
The mean of three values of each mouse was recorded.
Rota‑rod assay
The Ugo Basile Rota-rod instrument (COMERIO-Varese, 
Italy) has been used in this test. The mouse is placed on a 
horizontally oriented position and mechanically rotating 
at 15 rpm rod. The rod is suspended above a cage floor, 
which is high enough for avoidance of fall. Mice naturally 
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try to stay on the rotating rod, or Rota-rods, and avoid 
falling to the ground. The length of time that a given ani-
mal stays on this rotating rod is considered as a measure 
of their balance, coordination, and motor-activity.
Sample collection
For histological studies, brains were removed and cut 
into small pieces in sterile saline solution, fixed in 10 % 
neutral buffered formalin and embedded in paraffin. For 
biochemical investigations, samples were prepared by 
weighing 200  mg of longitudinal brain sections into a 
dry and clean Teflon digestion beaker, to which, 6 ml of 
HNO3, 2 ml HCl and 2 ml HF were added. Samples were 
digested on the hot plate at 120–150 °C for 40 min. The 
resulting digest was filtered through whatman filtered 
paper no42. The filtered digest was transferred to a 50 ml 
plastic volumetric flask and completed to the mark using 
deionized water.
Histological studies
For the histological slides preparation, left loop of cer-
ebellum, cerebral cortex and medulla oblongata of three 
sacrificed animals were fixed in 20 % formalin saline for 
24 h. To remove the excess of the fixative, the tissues were 
washed and then dehydrated in ascending grades (70, 
80, 90 and 95 %) of ethanol for 45 min each, then in two 
changes of absolute ethanol for 30 min each. This was fol-
lowed by two changes of xylene for 30 min each. The tis-
sues were then impregnated and embedded in paraplast 
plus. Sections (4–5 µm) were prepared with a microtome, 
de-waxed, hydrated and stained in Mayer’s haemalum 
solution for 3 min. The sections were stained in Eosin for 
one min, washed in tap water and dehydrated in ethanol 
as described above.
Neurochemical studies
Dopamine and serotonin determination
The level of dopamine and serotonin was estimated in the 
brain using the modified method of Patrick et al. [21]. A 
10  % homogenate of the brain has been re-centrifuged 
at 17,000  rpm at 4  °C for 5  min. The supernatants were 
filtered using 0.45  μm pore filters and analyzed by high 
performance liquid chromatography. The mobile phase 
consisted of 32  mM citric acid monohydrate, 12.5  mM 
disodium hydrogen orthophosphate, 7 % methanol, 1 mM 
octane sulfonic acid and 0.05  mM EDTA. The mobile 
phase was filtered through 0.22  μm filter and degassed 
under vacuum before use. Bondpak C18 column was used 
at a flow rate of 1.2 ml/min and the injection volume of 
the sample was 20 μl. The levels of dopamine and seroto-
nin were calculated using a calibration curve and results 
were expressed as ng/mg tissue weight.
Determination of acetylcholine
The level of acetylcholine was estimated in the brain 
using a method that has been described previously 
[22]. In brief, dialysate samples were injected into 
the liquid chromatography/electrochemistry system 
assisted by a chromatography manager (Millennium; 
Waters, Milford, MA), and analyzed for acetylcho-
line. Acetylcholine was separated on a coiled cation 
exchanger acetylcholine column (analytical column) 
(Sepstik 530  ×  1.0  mm I.D., packed with polymetric 
strong exchanger, 10 μm in diameter; BAS, West Lafay-
ette, IN), followed by the post-immobilized enzyme 
reactor which consisted of choline oxidase/acetylcho-
line esterase. Acetylcholine was hydrolyzed by ace-
tylcholine esterase to form acetate and choline in the 
post-immobilized enzyme reactor, and then choline 
was oxidized by choline oxidase to produce betaine 
and hydrogen peroxide (H2O2). H2O2 is detected via 
oxidation of horseradish peroxidase, which in turn 
entrapped in the redox polymer coated on the surface 
of the glassy carbon electrode (MF-9080; BAS), set 
at +100  mV (LC-4C; BAS) versus Ag/AgCl reference 
electrode. This reduction was analyzed with the detec-
tor (LC-4C; BAS) as a signal indicating acetylcholine 
on the chromatogram.
Reduced Glutathione (GSH) assay
Reduced glutathione content was determined according 
to the method of Beutler et  al. [23] with some modifi-
cation. Briefly, 0.20  ml of tissue supernatant was mixed 
with 1.5 ml of the precipitating solution which contains 
1.67 % glacial metaphosphoric acid, 0.20 % Na-EDTA and 
30 % NaCl. The mixture was allowed to stand for 5 min 
at room temperature and centrifuged at 1000  rpm for 
5  min. One ml clear supernatant was mixed with 4  ml 
0.30 M Na2HPO4 and 0.50 ml DTNB reagent (40 mg 5, 
5′dithiobis-(2-nitrobenzoic acid dissolved in 1 % sodium 
citrate). The blank was prepared similarly whereas 
0.20 ml water was used instead of the brain supernatant. 
The absorbance of the color was measure at 412 nm in a 
spectrophotometer.
Statistical analysis
Prior to further statistical analysis, the data were tested 
for normality using the Anderson–Darling test, as well as 
for homogeneity variances. The data was normally dis-
tributed and is expressed as the mean ±  standard error 
of the mean (SEM). Significant differences among the 
groups were analysed by one- or two-way ANOVA fol-
lowed by Tukey’s post-test using SPSS software, version 
17. Differences were considered statistically significant at 
P < 0.05.
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Results
Effect of KBrO3 on the body weight and water consumption 
of the treated mice
Figure  1a illustrates that during the first, the second and 
the last weeks of KBrO3 treatment, the high dose of KBrO3 
(200  mg/kg) was accompanied with a decrease in body 
weight in comparison to both the control group and the 
low dose treated group. On the other hand, the low dose of 
KBrO3 (100 mg/kg) effect on body weight decrease, was not 
significant. Water consumption was investigated to study 
its correlation with KBrO3 dose. As illustrated in Fig.  1b, 
the means of water consumption were similar between all 
KBrO3 exposure and control groups throughout the study.
KBrO3 treatment can cause a disturbance in the behavior 
of the treated mice
When investigating the behavior of animals in the 
T-maze, bad memory and low smell ability of the KBrO3 
treated groups during both the 3rd week and the 6th 
week in comparison to the control group was recorded. 
This was represented in the reduction of the number of 
entrances to the main arm (Fig.  2a), the increase in the 
time consumed to reach to the food in the food arm 
(Fig. 2b), the decrease in both of the number of entrances 
to the food arm (Fig. 2c) and the number of entrances to 
the empty arm (Fig.  2d). Additionally, the Moris—maze 
examination confirmed the observed bad memory in 
T-maze. Learning ability was also limited in both of the 
KBrO3 groups whereas they consumed much time to 
reach to the target (Fig.  3a) along four successive days. 
Still, the harmful effect of the high dose of KBrO3 is much 
more significant than that of the low dose one.
The fore-limb muscles of the animals in the group of 
the KBrO3 low dose recorded lower beaks in compari-
son to the control group in the grip strength examina-
tion scores. Moreover, the recorded beaks of the high 
dose KBrO3 group appeared significantly lower than the 
control group during both the 3rd and the 6th weeks 
(Fig. 3b).
In rotator test, both of the KBrO3 groups have exhib-
ited a short time on the rod during both the 3rd and the 
6th weeks in comparison to the animals of the control 
group. The staying times of the animals of the low dose 
KBrO3 group on the rod were less than the time of the 
control group. For the high dose KBrO3 group, the stay-
ing times of the animals on the rod were lower than that 
of the low dose group (Fig. 3c).
KBrO3 treatment is associated with depletion 
of neurotransmitters in the brain of the treated mice
Dopamine is an important neurotransmitter that plays 
a number of important roles in the brain. Conse-
quently, investigating the brain level of this molecule 
after KBrO3 treatment is of special relevance. In com-
parison to the control group (49.089 ± 0.634), a signif-
icant (*P < 0.05) depletion of dopamine concentration 
(39.338  ±  0.533) has been detected in the low dose 
KBrO3 group. Also, a highly significant (#P  <  0.05) 
reduction (26.672  ±  0.672) in the dopamine level in 
the high dose KBrO3 group in comparison to the con-
trol group was recorded (Fig.  4a). Another impor-
tant monoamine neurotransmitter is serotonin. Here, 
a significant (*P  <  0.05) reduction (2.331  ±  0.0664) 
in brain-serotonin concentration in the low dose 
KBrO3 group in comparison to the control group 
(3.243  ±  0.0943) was detected. Additionally, a highly 
significant (#P  <  0.05) decrease (1.756  ±  0.0525) in 
brain-serotonin concentration in the high dose KBrO3 
group in comparison to the control group was detected 
(Fig. 4b). Another organic molecule that acts as a neu-
rotransmitter is acetylcholine. Indeed, acetylcholine 
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Fig. 1 Effect of KBrO3 on the mean of body weight (gm) (a) and 
water consumption (ml) (b) in treated mice during six succes‑
sive weeks using two different doses of KBrO3. The data are the 
mean ± SEM for 10 mice per group for the control group (open white 
bars), low dose KBrO3 treated group (closed black bars), and high dose 
KBrO3 treated group (hatched bars). *P < 0.05 for low dose KBrO3 
treated group vs. control group; #P < 0.05 for high dose KBrO3 treated 
group vs. control group; +P<0.05 for high dose KBrO3 treated group 
vs. low dose KBrO3 treated group
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concentrations showed similar results to that of both 
dopamine and serotonin. In comparison to the con-
trol group (65.678  ±  0.627), acetylcholine concentra-
tion in the brain of the low dose KBrO3 group was 
significantly (*P  <  0.05) reduced (47.936  ±  0.459). 
Again, the brain level of acetylcholine in the high 
dose KBrO3 group was significantly (#P  <  0.05) lower 
(37.16  ±  0.728) than that of both the control group 
and the low dose KBrO3 group (Fig. 4c). This harmful 
effect of KBrO3 was dominant during both the 3rd and 
the 6th weeks.
Decreased brain level of reduced glutathione (GSH) 
after KBrO3 treatment in animals
Reduced glutathione (GSH) is an important antioxi-
dant that plays a crucial role in nearly all living organ-
isms. KBrO3 treatment had a negative effect on the brain 
level of this important molecule. In the low dose KBrO3 
group, the brain level of GSH was significantly (*P < 0.05) 
reduced (250.31  ±  39.61) in comparison to the control 
group (420.63  ±  59.61). Also, a significant (#P  <  0.05) 
reduction in the level of this crucial molecule was 
detected in the high dose KBrO3 group (110.76 ± 15.87) 
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Fig. 2 Effect of KBrO3 on the animal’s behavior in T‑maze. a The number of entrances of main arm. b The time consumed to reach to the food. c The 
number of entrances to the food arm. d The number of entrances to the empty arm. Data are expressed as mean ± SEM for 10 mice per group
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in comparison to either the control group or the low dose 
KBrO3 group (Fig. 5). Like neurotransmitters, the reduc-
ing effect of KBrO3 on the glutathione level, was domi-
nant during both the 3rd and the 6th weeks.
KBrO3 treatment has induced brain histopathological 
changes in mice
In the control group, the normal pyramidal neurons 
exhibited their general characteristic shape with rounded, 
large and centrally located nuclei (Fig.  6). The normal 
cells of the cerebral cortex had a spherical perikaryon 
whose nuclei were large. Also the neurons were arranged 
in a regular pattern (Fig. 6a, b). In both of KBrO3 treated 
groups, pyknosis and chromatolysis have been observed 
in the pyramidal neurons (Fig. 6c, d, e, f ).
In the cerebellum, the neuronal density in the molec-
ular layer of control group was the highest compared 
to KBrO3 treated groups. The normal Purkinje cells 
were arranged in a single row of large neurons with 
pear-shaped perikaryon and large nucleus. The lateral 
a
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processes disappeared and the apical processes formed 
the permanent dendritic tree (Fig.  7a, b). On the other 
hand, in both of KBrO3 treated groups, some degener-
ated Purkinje cells were detected and some were more 
spindle-shaped and small (Fig.  7c, d, e, f ). In control 
group, the normal neurons in the medulla appeared large 
in size, polygonal, varied in shape and had round nuclei 
(Fig.  8a, b). In both of KBrO3 treated groups, most of 
medulla neurons appeared small and pyknotic (Fig. 8c, d, 
e, f ). Also, degenerated medullary neurons were observed 
(Fig. 8 d, f ).
Discussion
Potassium bromate (KBrO3) is widely used as improv-
ing additive for bread making [7] and marketed as a neu-
tralizer in home permanent cold wave hair kits. Several 
cases of accidental poisoning in children resulting from 
the ingestion of KBrO3 solution, were reported [9]. Due 
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to its hazardous effects, it has been forbidden in various 
countries [2]. Toxicity studies in animals are commonly 
used to assess potential health risk in humans caused 
by intrinsic adverse effects of chemical compounds [24]. 
These adverse effects may manifest significant altera-
tions in the levels of bio molecules, normal functioning 
and histomorphology of the organs [3]. The current study 
was designed to investigate some of the behavioral and 
biochemical changes induced by KBrO3 intake in albino 
mice. We have observed that oral intubation of KBrO3 
at the dose of 200 mg/dl was accompanied with an obvi-
ous decrease in the body weight of the animals while 
the lower dose cannot do this effect. This is in agree-
ment with the results obtained by Kurokawa et  al. [25] 
who have reported a dose-dependent inhibition of body 
weight increase in both male and female F344 rats after 
oral administration of KBrO3. Also, similar results were 
obtained with guinea pigs [11]. Water consumption was 
not affected by the oral administration of KBrO3 with 
either the 100 or 200  mg/dl doses. These results agree 
with that of Dodd et al. [26] who have reported that only 
the 400 mg/L dose can result in a significant increase in 
water consumption and other lower doses cannot. Many 
environmental contaminants were reported to be associ-
ated with behavioral changes and this was elucidated in 
many studies before [27–31]. The abnormal pattern in 
open-field, social, learning and emotional behaviors were 
documented in Wister rats after receiving Sodium nitrite 
in the drinking water [32]. KBrO3-mediated behavio-
ral changes seen in the current study may be attributed 
partially to the harmful effect of KBrO3 on the brain 
level of neurotransmitters. It was reported that abnor-
malities in the regulation of neurotransmitter release 
and/or abnormal levels of extracellular neurotransmit-
ter concentrations are considered as core components 
of hypotheses on the neuronal foundations of behavioral 
Fig. 6 Effect of KBrO3 treatments on the Cerebral cortex of treated 
mice. Sagittal sections of the cerebral cortex depicting the pyramidal 
cell distribution (PYC), neurocytechromatolysis (NCH) and pyknosis 
(PKC) in the following groups: a, b control group, c, d potassium 
bromate 100 mg/kg group, e, f potassium bromate 200 mg/kg group. 
Scale bar 400 μm in a, c, e and 50 μm in b, d, f
Fig. 7 Effect of KBrO3 treatments on the Cerebellum of treated mice. 
Sagittal sections in the cerebellum cortex showing the degenerated 
Purkinje cell (DPC), fissure (FI), hemorrhage (H), internal granular layer 
(IGL), molecular layer (ML), Purkinje cell layer (PCL) and white matter 
(WM). a, b control group, c, d potassium bromate 100 mg/kg group, 
e, f potassium bromate200 mg/kg group. Scale bar 400 μm in a, c, e 
and 50 μm in b, d, f
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and cognitive disorders and the symptoms of neuropsy-
chiatric and neurodegenerative disorders [13]. GSH is the 
most abundant antioxidant  molecule that is critical for 
protecting the brain from oxidative stress, acting as a free 
radical scavenger and inhibitor of lipid peroxidation. In 
the current study, the decrease in the brain level of the 
antioxidant molecule, GSH, could be considered as an 
important reason for the observed behavioral changes. 
Previous reports have documented a direct relationship 
between behavioral changes and oxidative stress [33, 
34]. Oxidative stress can mediate neurodegeneration in 
hippocampus and behavioral changes of adult rats [35]. 
Concomitantly, KBrO3 induced pathological changes on 
the histological level in the brain tissue of the treated rats 
which may be considered as another important causa-
tive factor for the negative behavioral changes. Previous 
studies have reported hemorrhage, neuronal degenera-
tion and vacuolation of the brain tissue sections of rats 
after KBrO3 treatment [19]. Taken together, our data 
illustrate that oral administration of KBrO3 has a direct 
effect on the behavioral level, neurotransmitters content, 
antioxidant status and brain histomorphology of white 
albino rat and that using two different doses of KBrO3 
has different outcomes.
Conclusions
Potassium bromate has deleterious effects on the cen-
tral nervous system of mice. It can disturb the neuro-
transmitters levels, antioxidant defence molecules and 
induce histopathological changes in cerebral tissue. 
Therefore, its use in human used- products should be 
stopped.
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